Global Recombinant Human EGF Market, by Product Type (Heparin Binding-EGF, Transforming Growth Factor-α, Epigen, Neuregulins, Amphiregulin, Betacellulin, and Others), by Purity (98% SDS-PAGE, 95%-98% SDS-PAGE, and <95% SDS-PAGE), by Carrier Type (Carrier Protein and Carrier Free), by Formulation (Lyophilized Powder, Liquid, and Others), by Application (Wound Healing, Gastrointestinal Ulceration, Brain Tumor Therapy, and Others)and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 10,251.1 million in 2021, and is expected to exhibit a CAGR of 9.3% during the forecast period (2021-2028).
Get Your FREE Sample Copy of the Recombinant Human EGF Market Report 2021
Recombinant human EGF is used for the treatment of diabetic ulcers, thus the rising cases of diabetes is expected to drive growth of the global recombinant human EGF market during the forecast period. For instance, according to the International Diabetes Federation report published in September 2019, the global prevalence of diabetes was estimated to be 9.3%; however, it is expected to increase to 10.2% by 2030. The same source states that the number of people suffering from diabetes across the globe is expected to increase by 51% in 2045.
Growing research and development activities by public and private organizations is expected to drive growth of the global recombinant human EGF market. For instance, a research study published in Medical Military Journal in March 2021, investigated the potential efficiency of recombinant human EGF in wound healing when used in combination with vacuum sealing drainage (VSD). Both EGF and VSD are involved in wound healing and are reported to promote better healing when used together. This is expected to help in reducing the treatment time by decreasing the wound healing time. Such developments are expected to create new opportunities for recombinant human EGF market.
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/4515
Global Recombinant Human EGF Market – Impact of Coronavirus (COVID – 19) Pandemic
COVID-19 outbreak was first reported on December 31, 2019 in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 180 million cases and 3.9 million deaths due to Coronavirus (COVID-19) were reported up till June 27, 2021 across the globe.
The COVID-19 pandemic has affected several markets across the globe and is also expected to hamper the demand and supply in global recombinant human EGF market. The COVID-19 pandemic has led to a disruption of surgical procedures by halting several non-emergency surgeries. For instance, according to an article published by the National Centre for Biotechnology Information in 2019, over 1.1 million cases of ophthalmological surgeries in Monte Carlo were estimated to be at halt due to COVID-19 pandemic wherein the surgical procedures were not carried out post registration during the pandemic. This is expected to hamper the growth of recombinant human EGF market.
Moreover, developments in reimbursement policies of recombinant human EGF is expected to drive the recombinant human EGF market growth. For instance, in 2017, the national reimbursement drug list was revised to lift the restrictions on Healin, a recombinant human EGF product used for wound healing. The product is considered as a class B medical insurance product (class B covers outpatient prescription drugs and most of the commonly used medical drugs) manufactured by Shanghai Haohai Biological Technology Co., Ltd.
View Press Release For More Information
Key Takeaways of the Recombinant Human EGF Market:
- The global recombinant human EGF market is expected to exhibit a CAGR of 9.3% over the forecast period (2021-2028), owing to growing research in the field of recombinant human EGF. North America is expected to account for major market share over the forecast period (2021-2028) while Asia-Pacific region is expected to show potential growth in the recombinant human EGF market, owing to rising market strategies such as collaborations and partnerships. For instance, in 2019, Uni-Bio Science Group Limited, a Hong Kong based biopharmaceutical company announced partnership with Medlink, a U.K. based software solution provider to promote the marketing of its product GeneTime, which is a recombinant human EGF based prescription for treatment of ulcers.
- Some of the major players operating in the global recombinant human EGF market include Thermo Fisher Scientific, FUJIFILM Irvine Scientific, Inc., ScienCell Research Laboratories, R&D Systems, Abcam PLC, Cell Sciences, Inc., Eurofins DiscoverX, PeproTech, Inc., RayBiotech, Inc., Prospec-Tany TechnoGene Ltd., Miltenyi Biotec, Tonbo Biosciences, BioLegend, Inc., EnQuire BioReagents, STEMCELL Technologies Inc., Cell Guidance Systems Ltd., Creative BioMart, Sino Biological Inc., and BioVision, Inc.
Browse 29 Market Data Tables and 25 Figures spread through 157 Pages and in-depth TOC on Global Recombinant Human EGF Market, by Product Type (Heparin Binding-EGF, Transforming Growth Factor-α, Epigen, Neuregulins, Amphiregulin, Betacellulin, and Others), by Purity (98% SDS-PAGE, 95%-98% SDS-PAGE, and <95% SDS-PAGE), by Carrier Type (Carrier Protein and Carrier Free), by Formulation (Lyophilized Powder, Liquid, and Others), by Application (Wound Healing, Gastrointestinal Ulceration, Brain Tumor Therapy, and Others)and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the Recombinant Human EGF market press release
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Purity
- Market Snippet, By Carrier Type
- Market Snippet, By Formulation
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Porter’s Analysis
- Industry Trends
- Pipeline Analysis
- Key Highlights
- Epidemiology
- Pricing List
- Reimbursement Scenario of Recombinant Human EGF
- Regulatory Scenario
- Global Supply Chain Analysis
- Market Dynamics
- Global Recombinant Human EGF Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Recombinant Human EGF
- Impact of COVID-19 on the Recombinant Human EGF Market
- Global Recombinant Human EGF Market, By Product Type, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Heparin Binding-EGF
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Transforming Growth Factor-α
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Epigen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Neuregulins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Amphiregulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Betacellulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Recombinant Human EGF Market, By Purity, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- 98% SDS-PAGE
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- 95%-98% SDS-PAGE
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- <95% SDS-PAGE
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Recombinant Human EGF Market, By Carrier Type, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Carrier Protein
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Carrier Free
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Recombinant Human EGF Market, By Formulation, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Lyophilized Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Liquid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Recombinant Human EGF Market, By Application, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Wound Healing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Gastrointestinal Ulceration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Brain Tumor Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Recombinant Human EGF Market, By Region, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018 – 2028
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Purity, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Carrier Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Formulation, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Purity, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Carrier Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Formulation, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Purity, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Carrier Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Formulation, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Purity, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Carrier Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Formulation, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Purity, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Carrier Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Formulation, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Purity, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Carrier Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Formulation, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 – 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837